The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus)

Antiviral Research

Volumn 70, Issue 3, 2006, Pages 132-139

  Heraud, Jean Michel ^a   Mortreux, Frank ^b   Merien, Fabrice ^a   Contamin, Hugues ^a   Mahieux, Renaud ^c   Pouliquen, Jean Francois ^a   Wattel, Eric ^b   Gessain, Antoine ^c   de Thé, Hugues ^d   Bazarbachi, Ali ^e   Hermine, Olivier ^f   Kazanji, Mirdad ^a  

^a INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^b CENTRE LÉON BÉRARD   (France)

^c INSTITUT PASTEUR   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Arsenic; Flower cells; HTLV 1; Interferon alpha; Proviral load; Squirrel monkeys; Treatment

Indexed keywords

ALPHA INTERFERON; ARSENIC TRIOXIDE; CD3 ANTIGEN; RECOMBINANT ALPHA INTERFERON;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARSENIC POISONING; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CEBIDAE; CELL LINE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; LABORATORY TEST; LEUKOPENIA; LIVER DYSFUNCTION; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; SQUIRREL MONKEY; THROMBOCYTOPENIA; VIROGENESIS; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; ARSENICALS; CELL LINE, TRANSFORMED; DRUG THERAPY, COMBINATION; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON-ALPHA; MALE; OXIDES; SAIMIRI; TREATMENT OUTCOME;

HUMAN T-LYMPHOTROPIC VIRUS 1; SAIMIRI; SAIMIRI SCIUREUS;

EID: 33646797431     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.02.003     Document Type: Article

References (37)

1. Arnulf B., Thorel M., Poirot Y., Tamouza R., Boulanger E., Jaccard A., Oksenhendler E., Hermine O., and Pique C. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia 18 (2004) 126-132
2. Bangham C.R. The immune response to HTLV-I. Curr. Opin. Immunol. 12 (2000) 397-402
3. Bazarbachi A., El-Sabban M.E., Nasr R., Quignon F., Awaraji C., Kersual J., Dianoux L., Zermati Y., Haidar J.H., Hermine O., and de Thé H. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood 93 (1999) 278-283
4. Benvenisty N., Ornitz D.M., Bennett G.L., Sahagan B.G., Kuo A., Cardiff R.D., and Leder P. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene 7 (1992) 2399-2405
5. Cavrois M., Gessain A., Wain-Hobson S., and Wattel E. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 12 (1996) 2419-2423
6. Cavrois M., Leclercq I., Gout O., Gessain A., Wain-Hobson S., and Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 17 (1998) 77-82
7. Cavrois M., Wain-Hobson S., Gessain A., Plumelle Y., and Wattel E. Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood 88 (1996) 4646-4650
8. Chen Y.X., Ikeda S., Mori H., Hata T., Tsukasaki K., Momita S., Yamada Y., Kamihira S., Mine M., and Tomonaga M. Molecular detection of pre-ATL state among healthy HTLV-1 carriers in an endemic area of Japan. Int. J. Cancer 60 (1995) 798-801
9. Debacq C., Heraud J.M., Asquith B., Bangham C., Merien F., Moules V., Mortreux F., Wattel E., Burny A., Kettmann R., Kazanji M., and Willems L. Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene 24 (2005) 7514-7523
10. El-Sabban M.E., Nasr R., Dbaibo G., Hermine O., Abboushi N., Quignon F., Ameisen J.C., Bex F., de Thé H., and Bazarbachi A. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood 96 (2000) 2849-2855
11. Furuta Y., Aizawa S., Suda Y., Ikawa Y., Kishimoto H., Asano Y., Tada T., Hikikoshi A., Yoshida M., and Seiki M. Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I. J. Virol. 63 (1989) 3185-3189
12. Green J.E., Begley C.G., Wagner D.K., Waldmann T.A., and Jay G. Trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol. Cell. Biol. 9 (1989) 4731-4737
13. Hanon E., Hall S., Taylor G.P., Saito M., Davis R., Tanaka Y., Usuku K., Osame M., Weber J.N., and Bangham C.R. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95 (2000) 1386-1392
14. Hermine O., Bouscary D., Gessain A., Turlure P., Leblond V., Franck N., Buzyn-Veil A., Rio B., Macintyre E., Dreyfus F., and Bazarbachi A. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N. Engl. J. Med. 332 (1995) 1749-1751
15. Hermine O., Dombret H., Poupon J., Arnulf B., Lefrere F., Rousselot P., Damaj G., Delarue R., Fermand J.P., Brouet J.C., Degos L., Varet B., de Thé H., and Bazarbachi A. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. Hematol. J. 5 (2004) 130-134
16. Hinuma Y., Komoda H., Chosa T., Kondo T., Kohakura M., Takenaka T., Kikuchi M., Ichimaru M., Yunoki K., Sato I., Matsuo R., Takiuchi Y., Uchino H., and Hanaoka M. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int. J. Cancer 29 (1982) 631-635
17. Ibrahim F., Fiette L., Gessain A., Buisson N., de Thé G., and Bomford R. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. Int. J. Cancer 58 (1994) 446-451
18. Kazanji M. HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection. AIDS Res. Hum. Retroviruses 16 (2000) 1741-1746
19. Kazanji M., Bomford R., Bessereau J.L., Schulz T., and de The G. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene. Int. J. Cancer 71 (1997) 300-307
20. Kazanji M., Ibrahim F., Fiette L., Bomford R., and de The G. Role of the genetic background of rats in infection by HTLV-I and HTLV-II and in the development of associated diseases. Int. J. Cancer 73 (1997) 131-136
21. Kazanji M., Moreau J.-P., Mahieux R., Bonnemains B., Bomford R., Gessain A., and de Thé G. HTLV-I infection in squirrel monkey (Saïmiri sciureus) using autologous, homologous or heterologous HTLV-I-transformed cell lines. Virology 231 (1997) 258-266
22. Kazanji M., Ureta-Vidal A., Ozden S., Tangy F., de Thoisy B., Fiette L., Talarmin A., Gessain A., and de The G. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses. J. Virol. 74 (2000) 4860-4867
23. Leclercq I., Cavrois M., Mortreux F., Hermine O., Gessain A., Morschhauser F., and Wattel E. Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites. Br. J. Haematol. 101 (1998) 500-506
24. Leclercq I., Mortreux F., Morschhauser F., Duthilleul P., Desgranges C., Gessain A., Cavrois M., Vernant J.P., Hermine O., and Wattel E. Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL). Br. J. Haematol. 105 (1999) 743-751
25. Li X.H., and Gaynor R.B. Regulation of NF-kappaB by the HTLV-1 Tax protein. Gene Exp. 7 (1999) 233-245
26. Mahieux R., Pise-Masison C., Gessain A., Brady J.N., Olivier R., Perret E., Misteli T., and Nicot C. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood 98 (2001) 3762-3769
27. Mortreux F., Kazanji M., Gabet A.S., de Thoisy B., and Wattel E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J. Virol. 75 (2001) 1083-1089
28. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., Hashiguchi S., Ichinose M., Bangham C.R., Izumo S., and Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4 (1998) 586-593
29. Nakada K., Yamaguchi K., Furugen S., Nakasone T., Nakasone K., Oshiro Y., Kohakura M., Hinuma Y., Seiki M., Yoshida M., et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int. J. Cancer 40 (1987) 145-148
30. Nasr R., Rosenwald A., El-Sabban M.E., Arnulf B., Zalloua P., Lepelletier Y., Bex F., Hermine O., Staudt L., de The H., and Bazarbachi A. Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood 101 (2003) 4576-4582
31. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79 (1991) 428-437
32. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., and Warrell Jr. R.P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339 (1998) 1341-1348
33. Taylor G.P., Tosswill J.H., Matutes E., Daenke S., Hall S., Bain B.J., Davis R., Thomas D., Rossor M., Bangham C.R., and Weber J.N. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J. Acquir. Immune Defic. Syndr. 22 (1999) 92-100
34. Tsukasaki K., Tsushima H., Yamamura M., Hata T., Murata K., Maeda T., Atogami S., Sohda H., Momita S., Ideda S., Katamine S., Yamada Y., Kamihira S., and Tomonaga M. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood 89 (1997) 948-956
35. Waldmann T.A., White J.D., Goldman C.K., Top L., Grant A., Bamford R., Roessler E., Horak I.D., Zaknoen S., Kasten-Sportes C., England R., Horak E., Mishra B., Dipre M., Hale P., Fleisher T.A., Junghans R.P., Jaffe E.S., and Nelson D.L. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 82 (1993) 1701-1712
36. Yamamoto H., Sekiguchi T., Itagaki K., Saijo S., and Iwakura Y. Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthritis Rheum. 36 (1993) 1612-1620
37. Yoshida M., Seiki M., Yamaguchi K., and Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2534-2537